Skip to main content
Premium Trial:

Request an Annual Quote

FDA Grants Emergency Use Authorization for UMass Amherst COVID-19 Molecular Test

NEW YORK — The US Food and Drug Administration on Wednesday granted Emergency Use Authorization for a PCR-based COVID-19 test developed by the University of Massachusetts, Amherst.

The ICTC SARS-CoV-2 RT-PCR Assay is designed for the qualitative detection of nucleic acid from SARS-CoV-2 in anterior nasal swab specimens from people suspected of having COVID-19. Use of the test is limited to UMass Amherst's CLIA-certified IALS Clinical Testing Center, according to the FDA.

The testing center was established at the university's Institute for Applied Life Sciences as a surge facility to provide COVID-19 testing for the UMass Amherst campus and other regional campuses.

The Scan

Open Pediatric Brain Tumor Atlas Team Introduces Genomic Data Collection, Analytical Tools

A study in Cell Genomics outlines open-source methods being used to analyze and translate whole-genome, exome, and RNA sequence data from the Pediatric Brain Tumor Atlas.

Neurological Outcomes Linked to Innate Immune Features After Cardiac Arrest

Researchers reporting in Med dig into immune features found a few hours after cardiac arrest that correspond with neurological outcomes.

Mouse Study Finds Circadian Rhythm-Related Gene Expression Changes Linked to Sleep Apnea

A paper in PLOS Biology reveals tissue-specific circadian rhythm and gene expression patterns in an intermittent hypoxia-based mouse model of obstructive sleep apnea.

Polygenic Risk Score to Predict Preeclampsia, Gestational Hypertension in Pregnant Women

Researchers in Nature Medicine provide new mechanistic insights into the development of hypertensive disorders of pregnancy, which may help develop therapeutics.